IL110688A - N-substituted 3,4-Dihydro-2H-pyrano [2,3.X]-Pyridine alkanamines their preparation and pharmaceutical compositions containing them - Google Patents

N-substituted 3,4-Dihydro-2H-pyrano [2,3.X]-Pyridine alkanamines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL110688A
IL110688A IL11068894A IL11068894A IL110688A IL 110688 A IL110688 A IL 110688A IL 11068894 A IL11068894 A IL 11068894A IL 11068894 A IL11068894 A IL 11068894A IL 110688 A IL110688 A IL 110688A
Authority
IL
Israel
Prior art keywords
hydrogen
amino
formula
6alkyl
mono
Prior art date
Application number
IL11068894A
Other languages
English (en)
Other versions
IL110688A0 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL110688A0 publication Critical patent/IL110688A0/xx
Publication of IL110688A publication Critical patent/IL110688A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL11068894A 1993-08-19 1994-08-17 N-substituted 3,4-Dihydro-2H-pyrano [2,3.X]-Pyridine alkanamines their preparation and pharmaceutical compositions containing them IL110688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93202440 1993-08-19

Publications (2)

Publication Number Publication Date
IL110688A0 IL110688A0 (en) 1994-11-11
IL110688A true IL110688A (en) 1998-10-30

Family

ID=8214053

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11068894A IL110688A (en) 1993-08-19 1994-08-17 N-substituted 3,4-Dihydro-2H-pyrano [2,3.X]-Pyridine alkanamines their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US5691344A (cs)
EP (1) EP0714395B1 (cs)
JP (1) JP3650398B2 (cs)
KR (1) KR100330697B1 (cs)
CN (1) CN1051085C (cs)
AT (1) ATE178330T1 (cs)
AU (1) AU684819B2 (cs)
BR (1) BR9407298A (cs)
CA (1) CA2168022C (cs)
CZ (1) CZ286645B6 (cs)
DE (1) DE69417560T2 (cs)
DK (1) DK0714395T3 (cs)
ES (1) ES2132424T3 (cs)
FI (1) FI113773B (cs)
GR (1) GR3029924T3 (cs)
HU (1) HU228673B1 (cs)
IL (1) IL110688A (cs)
MY (1) MY111419A (cs)
NO (1) NO315001B1 (cs)
NZ (1) NZ271383A (cs)
PL (1) PL177516B1 (cs)
RO (1) RO116729B1 (cs)
RU (1) RU2135501C1 (cs)
SI (1) SI0714395T1 (cs)
SK (1) SK282108B6 (cs)
WO (1) WO1995005381A1 (cs)
ZA (1) ZA946268B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
DE19950647A1 (de) * 1999-10-21 2001-04-26 Merck Patent Gmbh Imidazolderivate als Phosphodiesterase VII-Hemmer
US6818659B2 (en) 2001-11-06 2004-11-16 Bristol-Myers Squibb Pharma, Inc. (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides
CN109476675B (zh) * 2016-07-01 2022-12-09 爱尔兰詹森科学公司 用于治疗病毒性感染的二氢吡喃并嘧啶衍生物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU403673A1 (ru) * 1971-10-05 1973-10-26 Авторы изобретени витель Способ получения 2-амино-4н-пирано
SU466228A1 (ru) * 1973-02-28 1975-04-05 Дальневосточный государственный университет Способ получени 2,4-дифенил-7,7диметилтетрагидропирано(4,3-в)пиперидина
SU943240A1 (ru) * 1980-05-28 1982-07-15 Пермский государственный фармацевтический институт Способ получени производных 10-окси-10н-пиридо [2,3- @ ХРОМЕНОВ
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
AU576868B2 (en) * 1984-06-11 1988-09-08 E.I. Du Pont De Nemours And Company Thiophene and pyridine sulfonamides
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
US5250450A (en) * 1991-04-08 1993-10-05 Micron Technology, Inc. Insulated-gate vertical field-effect transistor with high current drive and minimum overlap capacitance
DE4120322A1 (de) * 1991-06-20 1992-12-24 Bayer Ag Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
FI960721A0 (fi) 1996-02-16
CZ37396A3 (en) 1996-05-15
WO1995005381A1 (en) 1995-02-23
DE69417560T2 (de) 1999-11-11
FI113773B (fi) 2004-06-15
CN1051085C (zh) 2000-04-05
NO315001B1 (no) 2003-06-23
SK282108B6 (sk) 2001-11-06
RU2135501C1 (ru) 1999-08-27
NO960647D0 (no) 1996-02-19
MY111419A (en) 2000-04-29
US5691344A (en) 1997-11-25
CZ286645B6 (cs) 2000-05-17
DE69417560D1 (de) 1999-05-06
KR100330697B1 (ko) 2002-10-04
DK0714395T3 (da) 1999-10-11
NO960647L (no) 1996-02-19
HU228673B1 (en) 2013-05-28
ATE178330T1 (de) 1999-04-15
HU9600374D0 (en) 1996-04-29
EP0714395B1 (en) 1999-03-31
FI960721A7 (fi) 1996-02-16
AU684819B2 (en) 1998-01-08
CA2168022A1 (en) 1995-02-23
AU7499594A (en) 1995-03-14
BR9407298A (pt) 1996-10-01
GR3029924T3 (en) 1999-07-30
NZ271383A (en) 1997-05-26
IL110688A0 (en) 1994-11-11
CA2168022C (en) 2006-11-21
JPH09501669A (ja) 1997-02-18
RO116729B1 (ro) 2001-05-30
SI0714395T1 (en) 1999-08-31
SK19496A3 (en) 1997-02-05
EP0714395A1 (en) 1996-06-05
CN1129943A (zh) 1996-08-28
PL177516B1 (pl) 1999-12-31
PL313080A1 (en) 1996-05-27
ES2132424T3 (es) 1999-08-16
ZA946268B (en) 1996-02-19
HUT74676A (en) 1997-01-28
JP3650398B2 (ja) 2005-05-18

Similar Documents

Publication Publication Date Title
US5824682A (en) Vasoconstrictive dihydrobenzopyran derivatives
JP3819933B2 (ja) 血管収縮性ジヒドロベンゾピラン誘導体
EP0639192B1 (en) (benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
US5688799A (en) 9-Hydroxy-pyrido 1,2-a!pyrimidin-4-one ether derivatives
EP0714388B1 (en) Vasoconstrictive substituted aryloxyalkyl diamines
IL110688A (en) N-substituted 3,4-Dihydro-2H-pyrano [2,3.X]-Pyridine alkanamines their preparation and pharmaceutical compositions containing them
AU692361B2 (en) Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired